HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer

scientific article published on 24 March 2020

HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41598-020-61567-1
P932PMC publication ID7093413
P698PubMed publication ID32210254

P50authorJung Ho KimQ89340476
Kwang An KwonQ89340492
Dong Kyun ParkQ89340494
Sungjin ParkQ89518808
Seungyoon NamQ89518809
P2093author name stringJungsuk An
Sanghoon Han
Woon Kee Lee
Jun-Young Yang
Yoon Jae Kim
Kyoung Oh Kim
Jun-Won Chung
P2860cites workHER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the StomachQ26780318
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialQ27851578
Comprehensive molecular characterization of gastric adenocarcinomaQ28244985
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortalQ28288215
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014Q33584023
Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptorsQ33767107
Effects of screening on gastric cancer management: comparative analysis of the results in 2006 and in 2011.Q33927580
Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centersQ34620983
Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancerQ34932726
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas.Q35889941
Assessment of a HER2 scoring system for gastric cancer: results from a validation studyQ37142266
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic targetQ37149210
Predicting lymph node status in early gastric cancerQ37282324
Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer MortalityQ38986387
Integrated genomic characterization of oesophageal carcinomaQ39041152
Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysisQ39363485
Japanese gastric cancer treatment guidelines 2014 (ver. 4).Q39656427
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.Q40592991
Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registryQ43525350
Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.Q48379063
HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics CommitteeQ50036642
The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis.Q51805852
Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature.Q53134672
Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees.Q53511404
HER2/neu over-expression predicts poor outcome in early gastric cancer without lymph node metastasis.Q54325866
Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative studyQ56763795
Early HER2 dysregulation in gastric and oesophageal carcinogenesisQ58003579
Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian studyQ80135910
Japanese classification of gastric carcinoma: 3rd English editionQ84106763
Is endoscopic resection an alternative to surgery for early low-risk submucosal gastric cancers: analysis of a large surgical databaseQ85709378
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyQ88889087
Sex-specific differences in risk factors of lymph node metastasis in patients with early gastric cancerQ90797232
Pretreatment diagnosis factors associated with overtreatment with surgery in patients with differentiated-type early gastric cancerQ90950790
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissuesQ92502340
P433issue1
P921main subjectbiomarkerQ864574
lymph node metastasisQ2774221
P304page(s)5270
P577publication date2020-03-24
P1433published inScientific ReportsQ2261792
P1476titleHER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
P478volume10

Search more.